New drug trial aims to control serious fatty liver disease
Disease control
Recruiting now
This study is testing the safety and effectiveness of a drug called Resmiterom for people with MASH, a serious type of fatty liver disease that can lead to scarring. It will involve 165 patients in Pakistan who have been diagnosed with MASH and at least one related health conditi…
Phase: PHASE4 • Sponsor: Nabiqasim Industries (Pvt) Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC